USE OF RECOMBINANT HUMAN ERYTHROPOIETIN (rHuEPO) …

3 Approved 02/05/2008 A total of 1302 patients were randomized to placebo (n=652) or rHuEPO (n=650). Baseline characteristics were similar between groups except for a significantly higher iron and transferrin saturation

  Saturation, Erythropoietin, Transferrin saturation, Transferrin